Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Ventripoint Diagnostics Ltd (VPT.VN)

Ventripoint Diagnostics Ltd (VPT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 22,335
  • Shares Outstanding, K 159,534
  • Annual Sales, $ 49 K
  • Annual Income, $ -4,872 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.30
  • Price/Sales 304.98
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.03
  • Most Recent Earnings $-0.01 on 08/29/24
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Medical Devices

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.135 +3.70%
on 11/14/24
0.165 -15.15%
on 10/21/24
-0.020 (-12.50%)
since 10/18/24
3-Month
0.135 +3.70%
on 11/14/24
0.208 -32.69%
on 08/21/24
-0.045 (-24.32%)
since 08/20/24
52-Week
0.135 +3.70%
on 11/14/24
0.360 -61.11%
on 01/08/24
-0.005 (-3.45%)
since 11/20/23

Most Recent Stories

More News
Ventripoint Announces New Sales Program to Accelerate Growth in U.S. Market for AI-Powered Echocardiography Solutions

Toronto, Ontario / YOLOWIRE / November 19, 2024 / Ventripoint Diagnostics Ltd. (" Ventripoint " or the " Company "), (TSXV: $VPT) (OTC: $VPTDF) today announced the creation of a new sales program aimed...

VPT.VN : 0.140 (unch)
VPTDF : 0.0986 (-7.85%)
Ventripoint Receives EU CE Mark for Next Generation, AI-powered Heart-scanning Technology

Toronto, Ontario / Yolowire / October 24, 2024 /  Ventripoint Diagnostics Ltd. (" Ventripoint " or the " Company "), (TSXV:VPT; OTCQB:VPTDF) a leader in whole %HeartAnalysis technology, is pleased to...

VPT.VN : 0.140 (unch)
VPTDF : 0.0986 (-7.85%)
The Evolution of Cardiac Imaging: Impending Market Growth Fuels Innovation; Fusion with AI

The %CardiacImaging software market israpidly evolving,having reached a global size of 584.7 Million in 2023 . Thisremarkable growth, projected to continue at a compound annual growth rate(CAGR) of 8.5%...

VPT.VN : 0.140 (unch)
VPTDF : 0.0986 (-7.85%)
Stocks in play: Ventripoint Diagnostics Ltd.

Has submitted its next generation of software and hardware, VMS+4.0, for approval under the European ...

VPT.VN : 0.140 (unch)
AI Powered Heart Imaging Solutions Improve Heart Care With a Cheaper, Faster Alternative to MRIs

Heart disease remains the leading cause of death worldwide, highlighting the critical need for advanced cardiac imaging. The global ultrasound equipment market, projected to grow from $7.8 billion in 2021...

VPT.VN : 0.140 (unch)
VPTDF : 0.0986 (-7.85%)
AI Enters The Ultrasound Cardiac Diagnostics Landscape – And An Expanding Canadian Manufacturer Finds Itself At A Key Tech Intersection

A new report on the state and future of the global ultrasound heart diagnostics market sees the sector securing a 6.0% CAGR over the 2021-2026 period – and expects a sharp increase in cardiac cases to...

VPT.VN : 0.140 (unch)
Stocks in play: Ventripoint Diagnostics Ltd.

Has successfully completed the Medical Device Single Audit Program re-certification for its Quality ...

VPT.VN : 0.140 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It develops applications for heart diseases and imaging modalities which includes congenital heart disease, left or right heart failure,...

See More

Key Turning Points

3rd Resistance Point 0.148
2nd Resistance Point 0.147
1st Resistance Point 0.143
Last Price 0.140
1st Support Level 0.138
2nd Support Level 0.137
3rd Support Level 0.133

See More

52-Week High 0.360
Fibonacci 61.8% 0.274
Fibonacci 50% 0.248
Fibonacci 38.2% 0.221
Last Price 0.140
52-Week Low 0.135

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar